Back to mobile site

More on HIMS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-129.4% Growth)
- Ratings (3.9 Score)

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Hims & Hers Health, Inc. (NY:HIMS)
Delayed: 26.81 -2.06 (7.14%)
Prev. Close $28.87  
Open$28.68 
52 Wk High$ 
52 Wk Low$ 
Day High$28.78 
Day Low$26.52 
P/E N/A  
EPS$ 
Volume13,701,231 

Friends, Peers and Foes (?): NVO, LLY, AMZN, LFMD, CVS (more...)

Jun 4, 2026 09:00 AM Hims & Hers appoints Dr. Anant Vinjamoori as chief medical officer
Jun 4, 2026 09:00 AM Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
Jun 3, 2026 07:05 AM Canaccord Reiterates Buy Rating on Hims and Hers (HIMS)
Jun 2, 2026 08:19 AM Leerink Reiterates Market Perform Rating on Hims and Hers (HIMS)
Jun 2, 2026 06:09 AM Form 8-K Hims & Hers Health, Inc. For: May 29
Jun 2, 2026 05:00 AM Hims & Hers completes acquisition of Eucalyptus
Jun 2, 2026 05:00 AM HIMS & HERS completes Eucalyptus acquisition to expand in Canada
Jun 2, 2026 05:00 AM Hims & Hers completes Eucalyptus acquisition to expand in Germany
Jun 2, 2026 05:00 AM Hims & Hers completes Eucalyptus acquisition, enters Australia market
Jun 2, 2026 05:00 AM HIMS & Hers completes acquisition of Eucalyptus to enter Japan market
View All Articles

Entities mentioned with HIMS

View All Entities